Nifty
Sensex
:
:
13817.55
46874.36
-149.95 (-1.07%)
-535.57 (-1.13%)

Pharmaceuticals & Drugs - Domestic

Rating :
64/99  (View)

BSE: 540596 | NSE: ERIS

623.10
12.40 (2.03%)
28-Jan-2021 | 3:58PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  604.45
  •  639.00
  •  602.10
  •  610.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  339315
  •  2114.27
  •  643.20
  •  321.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,292.12
  • 26.22
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,224.80
  • 0.47%
  • 5.85

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.23%
  • 0.15%
  • 23.64%
  • FII
  • DII
  • Others
  • 11.3%
  • 9.68%
  • 1.00%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 12.46
  • 8.19

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 16.46
  • 2.69

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 17.29
  • 0.27

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 24.27

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 7.37

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 22.33

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
329.99
284.79
15.87%
293.24
274.30
6.90%
248.57
214.82
15.71%
266.40
252.39
5.55%
Expenses
205.23
174.95
17.31%
189.18
169.79
11.42%
171.44
152.67
12.29%
189.62
158.87
19.36%
EBITDA
124.77
109.84
13.59%
104.07
104.51
-0.42%
77.12
62.15
24.09%
76.78
93.52
-17.90%
EBIDTM
37.81%
38.57%
35.49%
38.10%
31.03%
28.93%
28.82%
37.05%
Other Income
2.08
5.17
-59.77%
1.34
2.83
-52.65%
-0.76
11.73
-
8.47
10.29
-17.69%
Interest
0.45
0.51
-11.76%
0.41
0.91
-54.95%
0.35
4.43
-92.10%
0.39
5.11
-92.37%
Depreciation
10.56
11.73
-9.97%
10.36
11.51
-9.99%
14.34
11.21
27.92%
12.70
9.59
32.43%
PBT
115.84
102.77
12.72%
94.64
94.92
-0.29%
61.67
58.24
5.89%
72.16
89.11
-19.02%
Tax
8.12
10.06
-19.28%
5.62
10.87
-48.30%
5.61
4.36
28.67%
8.69
8.91
-2.47%
PAT
107.72
92.71
16.19%
89.02
84.05
5.91%
56.06
53.88
4.05%
63.47
80.20
-20.86%
PATM
32.64%
32.55%
30.36%
30.64%
22.55%
25.08%
23.82%
31.77%
EPS
7.93
6.74
17.66%
6.56
6.11
7.36%
4.13
3.93
5.09%
4.62
5.83
-20.75%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
1,138.20
1,074.06
982.16
848.10
749.50
597.02
545.56
508.82
393.06
273.94
Net Sales Growth
10.90%
9.36%
15.81%
13.16%
25.54%
9.43%
7.22%
29.45%
43.48%
 
Cost Of Goods Sold
201.33
171.53
153.70
134.06
104.63
98.48
99.73
98.73
73.73
49.50
Gross Profit
936.87
902.53
828.46
714.03
644.86
498.54
445.83
410.09
319.34
224.44
GP Margin
82.31%
84.03%
84.35%
84.19%
86.04%
83.50%
81.72%
80.60%
81.24%
81.93%
Total Expenditure
755.47
706.17
637.08
525.98
480.36
425.32
424.10
409.87
307.12
215.37
Power & Fuel Cost
-
4.62
3.45
3.17
3.02
3.59
4.89
1.32
1.15
0.84
% Of Sales
-
0.43%
0.35%
0.37%
0.40%
0.60%
0.90%
0.26%
0.29%
0.31%
Employee Cost
-
205.69
190.66
157.32
131.22
124.67
125.63
90.54
67.31
42.97
% Of Sales
-
19.15%
19.41%
18.55%
17.51%
20.88%
23.03%
17.79%
17.12%
15.69%
Manufacturing Exp.
-
13.96
7.81
4.89
12.55
7.87
6.78
3.67
4.63
1.90
% Of Sales
-
1.30%
0.80%
0.58%
1.67%
1.32%
1.24%
0.72%
1.18%
0.69%
General & Admin Exp.
-
133.86
142.38
116.86
150.26
104.36
115.43
101.84
92.29
77.12
% Of Sales
-
12.46%
14.50%
13.78%
20.05%
17.48%
21.16%
20.01%
23.48%
28.15%
Selling & Distn. Exp.
-
163.59
134.82
107.67
76.82
82.75
70.90
113.44
63.42
42.76
% Of Sales
-
15.23%
13.73%
12.70%
10.25%
13.86%
13.00%
22.29%
16.13%
15.61%
Miscellaneous Exp.
-
12.93
4.25
2.00
1.86
3.59
0.74
0.34
4.60
0.27
% Of Sales
-
1.20%
0.43%
0.24%
0.25%
0.60%
0.14%
0.07%
1.17%
0.10%
EBITDA
382.74
367.89
345.08
322.12
269.14
171.70
121.46
98.95
85.94
58.57
EBITDA Margin
33.63%
34.25%
35.13%
37.98%
35.91%
28.76%
22.26%
19.45%
21.86%
21.38%
Other Income
11.13
16.01
31.69
26.41
25.11
3.37
3.49
4.42
1.45
1.31
Interest
1.60
2.30
23.06
10.65
1.10
0.28
0.02
0.28
0.77
1.19
Depreciation
47.96
50.26
36.35
25.64
22.76
20.36
15.51
4.77
3.48
3.21
PBT
344.31
331.35
317.36
312.23
270.39
154.44
109.42
98.33
83.14
55.48
Tax
28.04
34.84
26.21
17.25
23.78
19.59
20.16
27.41
24.70
18.42
Tax Rate
8.14%
10.51%
8.26%
5.52%
8.79%
12.68%
18.42%
27.88%
29.71%
33.20%
PAT
316.27
296.50
290.80
294.11
246.79
133.57
89.23
70.79
58.20
36.94
PAT before Minority Interest
316.27
296.51
291.15
294.98
246.61
134.86
89.26
70.91
58.44
37.06
Minority Interest
0.00
-0.01
-0.35
-0.87
0.18
-1.29
-0.03
-0.12
-0.24
-0.12
PAT Margin
27.79%
27.61%
29.61%
34.68%
32.93%
22.37%
16.36%
13.91%
14.81%
13.48%
PAT Growth
1.75%
1.96%
-1.13%
19.17%
84.76%
49.69%
26.05%
21.63%
57.55%
 
Unadjusted EPS
23.29
21.83
21.41
21.66
18.17
9.84
6.57
5.21
4.29
2.72

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
1,296.33
1,150.52
861.31
567.14
299.62
266.04
176.88
106.09
47.89
Share Capital
13.58
13.75
13.75
13.75
0.14
0.14
0.14
0.14
0.14
Total Reserves
1,279.90
1,135.57
847.56
553.39
299.49
265.91
176.74
105.95
47.75
Non-Current Liabilities
-79.63
-65.50
248.09
11.82
19.84
18.52
17.88
17.15
13.71
Secured Loans
0.00
0.29
274.19
0.49
0.00
0.50
0.00
0.56
2.58
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
25.98
19.39
18.71
22.96
23.10
19.99
17.02
15.23
8.92
Current Liabilities
220.17
377.25
293.98
129.27
68.95
65.49
71.27
43.55
35.28
Trade Payables
100.05
84.13
90.77
38.52
24.57
36.71
37.38
22.02
18.09
Other Current Liabilities
27.44
198.57
115.06
13.52
9.71
7.74
14.77
9.00
5.09
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
92.68
94.55
88.15
77.24
34.67
21.04
19.12
12.53
12.10
Total Liabilities
1,436.87
1,480.58
1,428.04
732.02
391.61
353.97
270.39
171.54
101.89
Net Block
874.85
760.54
771.09
231.65
71.37
71.74
74.92
26.88
23.18
Gross Block
983.89
838.26
819.52
254.43
123.31
103.73
91.43
38.75
32.10
Accumulated Depreciation
109.04
77.73
48.42
22.78
51.95
31.99
16.50
11.87
8.91
Non Current Assets
901.78
827.09
1,060.81
462.52
169.38
190.50
114.91
45.19
32.57
Capital Work in Progress
4.37
2.73
0.00
0.07
0.00
0.00
0.00
0.00
0.00
Non Current Investment
3.20
40.91
271.61
213.05
62.60
97.28
17.00
0.01
0.01
Long Term Loans & Adv.
13.49
17.03
12.11
12.84
35.41
21.48
22.98
18.30
9.38
Other Non Current Assets
5.86
5.88
6.00
4.91
0.00
0.00
0.00
0.00
0.00
Current Assets
535.10
653.49
367.23
269.50
222.24
163.48
155.48
126.36
69.32
Current Investments
74.78
314.94
93.76
90.18
127.44
69.24
66.96
46.50
13.45
Inventories
69.47
82.65
65.45
55.82
47.62
57.60
44.81
43.20
22.57
Sundry Debtors
156.88
83.98
66.64
48.86
25.37
23.67
22.34
16.60
14.45
Cash & Bank
67.33
7.51
10.64
2.42
9.69
5.72
7.29
4.90
9.33
Other Current Assets
166.64
57.56
44.37
4.71
12.11
7.25
14.08
15.17
9.53
Short Term Loans & Adv.
111.55
106.85
86.36
67.51
9.85
4.97
11.05
14.28
9.13
Net Current Assets
314.93
276.24
73.25
140.22
153.29
97.98
84.21
82.80
34.04
Total Assets
1,436.88
1,480.58
1,428.04
732.02
391.62
353.98
270.39
171.55
101.89

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
271.11
223.00
234.63
200.21
131.48
90.06
89.62
38.02
30.12
PBT
331.35
317.36
312.23
270.39
154.44
109.42
98.33
83.14
55.48
Adjustment
44.24
30.50
14.12
-0.65
19.92
12.15
0.69
6.91
3.03
Changes in Working Capital
-52.71
-53.24
-22.15
-16.45
-8.21
-8.06
20.73
-16.05
-10.80
Cash after chg. in Working capital
322.88
294.62
304.20
253.29
166.16
113.50
119.74
74.00
47.72
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-51.77
-71.63
-69.56
-53.08
-34.68
-23.44
-30.11
-35.98
-17.60
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
123.29
-5.05
-590.10
-184.46
-43.91
-92.13
-82.74
-35.67
-19.45
Net Fixed Assets
-145.49
-21.60
-419.73
-5.00
-22.68
-12.05
-52.56
-6.04
Net Investments
260.17
-34.87
-164.99
-174.29
-24.03
-84.69
-39.55
-38.93
Others
8.61
51.42
-5.38
-5.17
2.80
4.61
9.37
9.30
Cash from Financing Activity
-334.59
-221.05
363.21
-23.66
-83.70
0.46
-2.30
-3.12
-9.67
Net Cash Inflow / Outflow
59.81
-3.11
7.75
-7.91
3.87
-1.62
4.58
-0.77
1.00
Opening Cash & Equivalents
7.50
10.61
2.34
8.87
5.00
6.62
2.04
2.81
1.82
Closing Cash & Equivalent
67.31
7.50
10.61
2.34
8.87
5.00
6.62
2.04
2.81

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
95.26
83.57
62.64
41.25
21711.81
19278.55
12817.54
7687.54
3470.29
ROA
20.33%
20.02%
27.31%
43.89%
36.17%
28.59%
32.09%
42.75%
36.38%
ROE
24.28%
28.96%
41.30%
56.90%
47.68%
40.30%
50.12%
75.91%
77.39%
ROCE
25.44%
26.54%
35.76%
62.56%
54.56%
49.25%
68.93%
103.88%
107.17%
Fixed Asset Turnover
1.18
1.18
1.59
3.97
5.31
5.62
7.82
11.10
8.53
Receivable days
40.93
27.99
24.64
18.07
14.84
15.32
13.97
14.41
19.25
Inventory Days
25.85
27.52
25.87
25.19
31.85
34.10
31.57
30.54
30.07
Payable days
57.19
59.07
54.07
32.17
33.59
41.33
35.37
31.11
45.53
Cash Conversion Cycle
9.59
-3.57
-3.57
11.09
13.11
8.10
10.16
13.84
3.79
Total Debt/Equity
0.00
0.15
0.44
0.00
0.00
0.00
0.00
0.02
0.10
Interest Cover
145.25
14.76
30.31
246.14
558.56
4974.41
358.55
109.40
47.82

News Update


  • Eris Lifesciences - Quarterly Results
    3rd Nov 2020, 13:34 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.